about
Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy.Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population.Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controlsImmune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT RegistryPain assessment and management in haemophilia: A survey among Italian patients and specialist physiciansSevere bleeding in a patient with Factor XIII deficiency and COVID-19
P50
description
researcher
@en
wetenschapper
@nl
name
A Tagliaferri
@en
A Tagliaferri
@nl
type
label
A Tagliaferri
@en
A Tagliaferri
@nl
prefLabel
A Tagliaferri
@en
A Tagliaferri
@nl
P31
P496
0000-0003-3529-6334